Related Experiment Video
Updated: Dec 16, 2025
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Laparoscopic liver resection: indications, limitations, and economic aspects
Moritz Schmelzle1, Felix Krenzien2, Wenzel Schöning2
1Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. moritz.schmelzle@charite.de.
Laparoscopic liver surgery offers advantages, with increasing indications for tumors like liver metastasis and hepatocellular carcinoma. Ongoing evaluation of technical limits and cost-effectiveness is crucial for maintaining surgical quality standards.
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Minimally invasive techniques are increasingly adopted in liver surgery.
- Numerous retrospective studies suggest benefits of laparoscopic over open liver procedures.
- Rapid advancements necessitate an overview of current laparoscopic liver surgery status and future directions.
Purpose of the Study:
- To review current aspects of laparoscopic liver surgery.
- To discuss evolving indications and persistent technical limitations.
- To provide an assessment based on literature and center experience, including cost implications.
Main Methods:
- Literature review of current practices in laparoscopic liver surgery.
- Analysis of established and emerging indications.
- Evaluation of technical limitations and cost-effectiveness.
Main Results:
- Indications have expanded from benign tumors to include liver metastasis and hepatocellular carcinoma.
- Technical limitations persist and require careful assessment.
- Cost-effectiveness and reimbursement are significant considerations.
Conclusions:
- Laparoscopic liver surgery is expanding its scope beyond benign conditions.
- Addressing technical limitations is vital to uphold surgical quality standards.
- Financial viability and cost-covering reimbursement are essential for widespread adoption.
